naltrexone and Peritoneal Carcinomatosis

naltrexone has been researched along with Peritoneal Carcinomatosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Mendelsohn, RB; Nelson, KK; Schattner, MA	1

Other Studies

1 other study(ies) available for naltrexone and Peritoneal Carcinomatosis

Article	Year
Methylnaltrexone is safe in cancer patients with peritoneal carcinomatosis. Scientific reports, 2019, 07-03, Volume: 9, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Child; Child, Preschool; Constipation; Female; Humans; Infant; Male; Middle Aged; Naltrexone; Peritoneal Neoplasms; Quaternary Ammonium Compounds; Retrospective Studies; Treatment Outcome; Young Adult	2019

Article

Year

Methylnaltrexone is safe in cancer patients with peritoneal carcinomatosis.

Scientific reports, 2019, 07-03, Volume: 9, Issue:1

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Child; Child, Preschool; Constipation; Female; Humans; Infant; Male; Middle Aged; Naltrexone; Peritoneal Neoplasms; Quaternary Ammonium Compounds; Retrospective Studies; Treatment Outcome; Young Adult

2019